Featured News and Projects
Sanford is first in nation to test new COVID-19 treatment
Sanford is the first site in the nation to enroll patients in a phase 1b trial of a new therapy developed by Sioux Falls-based SAB Biotherapeutics. The new therapy is designed to treat people with mild to moderate COVID-19 at an early stage.
Aspiring doctor values research experience at Sanford LabA University of South Dakota MD-PhD candidate has spent the last few years in the Baack Lab at Sanford Research to complete the PhD portion of his dual degree. Eli has received national recognition for his work studying heart development.
Sanford cancer clinical trial shows improved outcomesFrom bench to bedside, Sanford's head and neck research team led a study incorporating an immunotherapy drug into the standard regimen for treating head and neck cancers
Sanford Research is home to four research centers. Each multidisciplinary center is defined by complementary scientific and technical expertise along with supporting resources to advance a thematic research goal. Thematic goals encompass: studying of complex behaviors and biological factors, improving the health of patients and communities using unique data-driven techniques, translating basic discoveries into clinical trials for humans, and enhancing children’s health research.
Sanford Health News
Expansion will allow for more flu and COVID-19 testing, with faster results
Sanford’s Dr. Murat Sincan looks at patterns of disease at Imagenetics, Research